Charles E. Cox

9.1k total citations · 1 hit paper
116 papers, 6.7k citations indexed

About

Charles E. Cox is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Charles E. Cox has authored 116 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Cancer Research, 61 papers in Pathology and Forensic Medicine and 46 papers in Oncology. Recurrent topics in Charles E. Cox's work include Breast Cancer Treatment Studies (75 papers), Breast Lesions and Carcinomas (59 papers) and Breast Implant and Reconstruction (32 papers). Charles E. Cox is often cited by papers focused on Breast Cancer Treatment Studies (75 papers), Breast Lesions and Carcinomas (59 papers) and Breast Implant and Reconstruction (32 papers). Charles E. Cox collaborates with scholars based in United States, Switzerland and India. Charles E. Cox's co-authors include Douglas S. Reintgen, Alan Cantor, Elisabeth Dupont, Ni Ni Ku, Claudia G. Berman, Christopher Salud, Eric Peltz, Cecile A. Lengacher, Kevin E. Kip and Keoni Nguyen and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Applied Psychology and Cancer.

In The Last Decade

Charles E. Cox

113 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

2001 654 citations Charles E. Cox et al. profile →

Peers

Countries citing papers authored by Charles E. Cox

Since Specialization

Citations

This map shows the geographic impact of Charles E. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Cox more than expected).

Fields of papers citing papers by Charles E. Cox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Cox. The network helps show where Charles E. Cox may publish in the future.

Co-authorship network of co-authors of Charles E. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Cox. A scholar is included among the top collaborators of Charles E. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Cox. Charles E. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy 2023 ·Annals of Surgical Oncology ·Peter Blumencranz, Mehran Habibi, Steven C. Shivers, Géza Ács, (unknown), (unknown), (unknown), Andrea Menicucci, Patricia Dauer, William Audeh, Charles E. Cox	6
2	Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters 2016 ·Journal of Pain and Symptom Management ·Richard R. Reich, Cecile A. Lengacher, Carissa B. Alinat, Kevin E. Kip, C R Paterson, Sophia Ramesar, Heather Han, Roohi Ismail‐Khan, Versie Johnson‐Mallard, Manolete S. Moscoso, Pinky Budhrani-Shani, Steven C. Shivers, Charles E. Cox, Matthew Goodman, Jong-Hak Park	134
3	Consequences of Axillary Ultrasound in Patients with T2 or Greater Invasive Breast Cancers 2010 ·Annals of Surgical Oncology ·M. Catherine Lee, (unknown), Alec Chau, Gang Han, John V. Kiluk, Nazanin Khakpour, Charles E. Cox, W. Bradford Carter, Christine Laronga	39
4	Sentinel Lymph Node Biopsy in Patients with Previous Ipsilateral Complete Axillary Lymph Node Dissection 2010 ·Annals of Surgical Oncology ·Paramjeet Kaur, John V. Kiluk, Tammi Meade, Daniel Ramos, (unknown), (unknown), Jeff King, Charles E. Cox	26
5	Pregnancy-Associated Breast Cancer Patients Can Safely Undergo Lymphatic Mapping 2008 ·The Breast Journal ·(unknown), John V. Kiluk, (unknown), Tammi Meade, Michael P. Meyers, Elisabeth Dupont, Claudia G. Berman, Charles E. Cox	59
6	Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer. 2007 ·PubMed ·Nirmal Lamichhane, Manohar Pradhan, (unknown), (unknown), Hari Prasad Dhakal, (unknown), Charles E. Cox	5
7	Significance of Sentinel Lymph Node Micrometastases in Human Breast Cancer 2007 ·Journal of the American College of Surgeons ·Charles E. Cox, John V. Kiluk, Adam I. Riker, John M. Cox, (unknown), Daniel Ramos, Elisabeth Dupont, Vesna Vrcel, Nils M. Diaz, David Boulware	99
8	Sentinel Node Biopsy Before Neoadjuvant Chemotherapy for Determining Axillary Status and Treatment Prognosis in Locally Advanced Breast Cancer 2006 ·Annals of Surgical Oncology ·Charles E. Cox, John M. Cox, Laura White, (unknown), John D. Clark, (unknown), Michael P. Meyers, Elisabeth Dupont, Ben Furman, Susan Minton	47
9	An update of sentinel lymph node mapping in patients with ductal carcinoma in situ 2005 ·The American Journal of Surgery ·(unknown), Laura White, Elisabeth Dupont, Alan Cantor, Charles E. Cox	104
10	Breast Cancer in Patients with Prior Augmentation: Presentation, Stage, and Lymphatic Mapping 2004 ·Plastic & Reconstructive Surgery ·James W. Jakub, Mark Ebert, Alan Cantor, Mary Gardner, Douglas S. Reintgen, Elisabeth Dupont, Charles E. Cox, Alan R. Shons	44
11	Effect of Lymphatic Mapping on Diagnosis and Treatment of Patients With T1a, T1b Favorable Breast Cancer 2003 ·Annals of Surgery ·James W. Jakub, Mark Ebert, Nils M. Diaz, Alan Cantor, Douglas S. Reintgen, Elisabeth Dupont, Alan R. Shons, Charles E. Cox	6
12	Radioactive Seed Localization Breast Biopsy and Lumpectomy: Can Specimen Radiographs Be Eliminated? 2003 ·Annals of Surgical Oncology ·Charles E. Cox, Ben Furman, (unknown), Mark Ebert, John D. Clark, (unknown), Alan R. Shons, Claudia G. Berman, (unknown), Mary Gardner, (unknown), (unknown), Margaret M. Szabunio, (unknown), Nils M. Diaz, Vesna Vrcel, (unknown)	49
13	Learning and credentialing in breast cancer sentinel lymph node biopsy 2002 ·Charles E. Cox, Mark Ebert, James W. Jakub	0
14	The specific role of isoflavones on estrogen metabolism in premenopausal women 2002 ·Cancer ·Nagi B. Kumar, Alan Cantor, Kathy Allen, Diane Riccardi, Charles E. Cox	92
15	Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes 2002 ·The American Journal of Surgery ·James W. Jakub, Nils M. Diaz, Mark Ebert, Alan Cantor, Douglas S. Reintgen, Elisabeth Dupont, Alan R. Shons, Charles E. Cox	42
16	Utility of Internal Mammary Lymph Node Removal When Noted by Intraoperative Gamma Probe Detection 2001 ·Annals of Surgical Oncology ·Elisabeth Dupont, Charles E. Cox, Keoni Nguyen, Christopher Salud, Eric Peltz, George F. Whitehead, Mark Ebert, Ni Ni Ku, Douglas S. Reintgen	34
17	Microstaging of Breast Cancer Patients Using Cytokeratin Staining of the Sentinel Lymph Node 1999 ·Annals of Surgical Oncology ·(unknown), Solange Pendas, Ni Ni Ku, Douglas S. Reintgen, Alan R. Shons, Claudia G. Berman, David Boulware, Charles E. Cox	72
18	Bilaterality and recurrence rates for lobular breast cancer: Considerations for treatment 1997 ·Annals of Surgical Oncology ·Timothy J. Yeatman, Gary H. Lyman, (unknown), Douglas S. Reintgen, Alan Cantor, Charles E. Cox	33
19	Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with dna flow cytometry, histopathology, and lymph node status 1992 ·Cancer ·Walid A. Mourad, (unknown), Sandra Livingston, Mohamed M. Shoukri, Charles E. Cox, Santo V. Nicosia, (unknown)	53
20	Breast Cancer of the Older Woman: An Annotated Review 1991 ·Journal of the American Geriatrics Society ·Lodovico Balducci, David V. Schapira, Charles E. Cox, Harvey Greenberg, Gary H. Lyman	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact